100 related articles for article (PubMed ID: 12635125)
1. Nerve growth factor expression in human dystrophic muscles.
Toti P; Villanova M; Vatti R; Schuerfeld K; Stumpo M; Barbagli L; Malandrini A; Costantini M
Muscle Nerve; 2003 Mar; 27(3):370-3. PubMed ID: 12635125
[TBL] [Abstract][Full Text] [Related]
2. Intramuscular renin-angiotensin system is activated in human muscular dystrophy.
Sun G; Haginoya K; Dai H; Chiba Y; Uematsu M; Hino-Fukuyo N; Onuma A; Iinuma K; Tsuchiya S
J Neurol Sci; 2009 May; 280(1-2):40-8. PubMed ID: 19232644
[TBL] [Abstract][Full Text] [Related]
3. [Degeneration and regeneration of striated skeletal muscle fibers in Duchenne muscular dystrophy].
Brasseur G; Onolfo JP; Copin H; Leperchey F; Barbet JP
Morphologie; 1997 Mar; 81(252):9-13. PubMed ID: 9737904
[TBL] [Abstract][Full Text] [Related]
4. Platelet-derived growth factor and its receptors are related to the progression of human muscular dystrophy: an immunohistochemical study.
Zhao Y; Haginoya K; Sun G; Dai H; Onuma A; Iinuma K
J Pathol; 2003 Sep; 201(1):149-59. PubMed ID: 12950028
[TBL] [Abstract][Full Text] [Related]
5. Expression of tumor necrosis factor-alpha in regenerating muscle fibers in inflammatory and non-inflammatory myopathies.
Kuru S; Inukai A; Kato T; Liang Y; Kimura S; Sobue G
Acta Neuropathol; 2003 Mar; 105(3):217-24. PubMed ID: 12557007
[TBL] [Abstract][Full Text] [Related]
6. Elevated plasma levels of tissue inhibitors of metalloproteinase-1 and their overexpression in muscle in human and mouse muscular dystrophy.
Sun G; Haginoya K; Chiba Y; Uematsu M; Hino-Fukuyo N; Tanaka S; Onuma A; Iinuma K; Tsuchiya S
J Neurol Sci; 2010 Oct; 297(1-2):19-28. PubMed ID: 20655547
[TBL] [Abstract][Full Text] [Related]
7. Activation and localization of matrix metalloproteinase-2 and -9 in the skeletal muscle of the muscular dystrophy dog (CXMDJ).
Fukushima K; Nakamura A; Ueda H; Yuasa K; Yoshida K; Takeda S; Ikeda S
BMC Musculoskelet Disord; 2007 Jun; 8():54. PubMed ID: 17598883
[TBL] [Abstract][Full Text] [Related]
8. Expression profiling of muscles from Fukuyama-type congenital muscular dystrophy and laminin-alpha 2 deficient congenital muscular dystrophy; is congenital muscular dystrophy a primary fibrotic disease?
Taniguchi M; Kurahashi H; Noguchi S; Sese J; Okinaga T; Tsukahara T; Guicheney P; Ozono K; Nishino I; Morishita S; Toda T
Biochem Biophys Res Commun; 2006 Apr; 342(2):489-502. PubMed ID: 16487936
[TBL] [Abstract][Full Text] [Related]
9. Distribution of ten laminin chains in dystrophic and regenerating muscles.
Patton BL; Connoll AM; Martin PT; Cunningham JM; Mehta S; Pestronk A; Miner JH; Sanes JR
Neuromuscul Disord; 1999 Oct; 9(6-7):423-33. PubMed ID: 10545049
[TBL] [Abstract][Full Text] [Related]
10. Fetal myosin immunoreactivity in human dystrophic muscle.
Schiaffino S; Gorza L; Dones I; Cornelio F; Sartore S
Muscle Nerve; 1986 Jan; 9(1):51-8. PubMed ID: 3513005
[TBL] [Abstract][Full Text] [Related]
11. Utility of dystrophin and utrophin staining in childhood muscular dystrophy.
Sundaram C; Vydehi B; Meena K; Murthy J
Indian J Pathol Microbiol; 2004 Jul; 47(3):367-9. PubMed ID: 16295426
[TBL] [Abstract][Full Text] [Related]
12. Maturational defect of regenerating muscle fibers in cases with Duchenne and congenital muscular dystrophies.
Miike T
Muscle Nerve; 1983 Oct; 6(8):545-52. PubMed ID: 6196637
[TBL] [Abstract][Full Text] [Related]
13. Nerve growth factor improves the muscle regeneration capacity of muscle stem cells in dystrophic muscle.
Lavasani M; Lu A; Peng H; Cummins J; Huard J
Hum Gene Ther; 2006 Feb; 17(2):180-92. PubMed ID: 16454652
[TBL] [Abstract][Full Text] [Related]
14. Dystrophin deficiency in canine X-linked muscular dystrophy in Japan (CXMDJ) alters myosin heavy chain expression profiles in the diaphragm more markedly than in the tibialis cranialis muscle.
Yuasa K; Nakamura A; Hijikata T; Takeda S
BMC Musculoskelet Disord; 2008 Jan; 9():1. PubMed ID: 18182116
[TBL] [Abstract][Full Text] [Related]
15. Endomysial fibrosis in Duchenne muscular dystrophy: a marker of poor outcome associated with macrophage alternative activation.
Desguerre I; Mayer M; Leturcq F; Barbet JP; Gherardi RK; Christov C
J Neuropathol Exp Neurol; 2009 Jul; 68(7):762-73. PubMed ID: 19535995
[TBL] [Abstract][Full Text] [Related]
16. The calcineurin signal transduction pathway is essential for successful muscle regeneration in mdx dystrophic mice.
Stupka N; Gregorevic P; Plant DR; Lynch GS
Acta Neuropathol; 2004 Apr; 107(4):299-310. PubMed ID: 14727129
[TBL] [Abstract][Full Text] [Related]
17. The RAGE pathway in inflammatory myopathies and limb girdle muscular dystrophy.
Haslbeck KM; Friess U; Schleicher ED; Bierhaus A; Nawroth PP; Kirchner A; Pauli E; Neundörfer B; Heuss D
Acta Neuropathol; 2005 Sep; 110(3):247-54. PubMed ID: 15986224
[TBL] [Abstract][Full Text] [Related]
18. Fibrosis-Inducing Strategies in Regenerating Dystrophic and Normal Skeletal Muscle.
Pessina P; Muñoz-Cánoves P
Methods Mol Biol; 2016; 1460():73-82. PubMed ID: 27492167
[TBL] [Abstract][Full Text] [Related]
19. Changes in skeletal muscle expression of AQP1 and AQP4 in dystrophinopathy and dysferlinopathy patients.
Au CG; Butler TL; Egan JR; Cooper ST; Lo HP; Compton AG; North KN; Winlaw DS
Acta Neuropathol; 2008 Sep; 116(3):235-46. PubMed ID: 18392839
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of 18 cases of Becker muscular dystrophy].
Bernal Sánchez-Arjona M; Sanz-Fernández G; Travado-Soria P; Fernández-García R; Chinchón-Lara I; Antiñolo G; Bautista-Lorite J
Rev Neurol; 2004 Jun 1-15; 38(11):1090-2. PubMed ID: 15202090
[No Abstract] [Full Text] [Related]
[Next] [New Search]